Abstract:
Summary
UTI is one major problem in the medicine. In treatment of UTI multiple therapeutic schemes are
folowed. 32 patients with acute and cronic UTI were treated using antibacterial monoterapy with
Abactal (LEK Pharmaceuticals dd). Positive rezults were found in 28 patients. While no change from
the prescristing condition was found in 4 (12%). Tolerance was found to be good in 84% patients.
Adverse effect were found in 16% patients. This antibactherial preparation has opened a new
perspective in the treatment of patients with urinary tract infection.